nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—PGD—Methotrexate—ankylosing spondylitis	0.308	0.374	CbGbCtD
Furosemide—ABCC2—Sulfasalazine—ankylosing spondylitis	0.126	0.153	CbGbCtD
Furosemide—SLC22A11—Methotrexate—ankylosing spondylitis	0.0914	0.111	CbGbCtD
Furosemide—ABCC2—Dexamethasone—ankylosing spondylitis	0.0629	0.0764	CbGbCtD
Furosemide—ALB—Prednisone—ankylosing spondylitis	0.0628	0.0763	CbGbCtD
Furosemide—SLC22A8—Methotrexate—ankylosing spondylitis	0.0531	0.0645	CbGbCtD
Furosemide—ABCC2—Methotrexate—ankylosing spondylitis	0.0506	0.0614	CbGbCtD
Furosemide—SLC22A6—Methotrexate—ankylosing spondylitis	0.037	0.0449	CbGbCtD
Furosemide—ALB—Methotrexate—ankylosing spondylitis	0.0315	0.0383	CbGbCtD
Furosemide—Urine output increased—Methotrexate—ankylosing spondylitis	0.000579	0.00328	CcSEcCtD
Furosemide—Purpura—Prednisone—ankylosing spondylitis	0.000577	0.00327	CcSEcCtD
Furosemide—Lethargy—Prednisone—ankylosing spondylitis	0.000568	0.00322	CcSEcCtD
Furosemide—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.000563	0.00319	CcSEcCtD
Furosemide—Muscular weakness—Betamethasone—ankylosing spondylitis	0.000563	0.00319	CcSEcCtD
Furosemide—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.000537	0.00305	CcSEcCtD
Furosemide—Diabetes mellitus—Methotrexate—ankylosing spondylitis	0.000534	0.00303	CcSEcCtD
Furosemide—Irritability—Prednisone—ankylosing spondylitis	0.000531	0.00301	CcSEcCtD
Furosemide—Photosensitivity—Methotrexate—ankylosing spondylitis	0.000529	0.003	CcSEcCtD
Furosemide—Polyuria—Methotrexate—ankylosing spondylitis	0.000529	0.003	CcSEcCtD
Furosemide—Sweating—Methylprednisolone—ankylosing spondylitis	0.000519	0.00294	CcSEcCtD
Furosemide—Visual impairment—Prednisolone—ankylosing spondylitis	0.00051	0.00289	CcSEcCtD
Furosemide—Hypokalaemia—Prednisone—ankylosing spondylitis	0.000506	0.00287	CcSEcCtD
Furosemide—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.000498	0.00282	CcSEcCtD
Furosemide—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.000498	0.00282	CcSEcCtD
Furosemide—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.000493	0.00279	CcSEcCtD
Furosemide—Muscular weakness—Prednisone—ankylosing spondylitis	0.000491	0.00278	CcSEcCtD
Furosemide—Abdominal distension—Prednisone—ankylosing spondylitis	0.000484	0.00274	CcSEcCtD
Furosemide—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.00048	0.00272	CcSEcCtD
Furosemide—Lethargy—Methotrexate—ankylosing spondylitis	0.000474	0.00269	CcSEcCtD
Furosemide—Arrhythmia—Prednisolone—ankylosing spondylitis	0.000473	0.00268	CcSEcCtD
Furosemide—Pancreatitis—Prednisone—ankylosing spondylitis	0.000471	0.00267	CcSEcCtD
Furosemide—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000468	0.00266	CcSEcCtD
Furosemide—Erythema—Prednisolone—ankylosing spondylitis	0.000461	0.00261	CcSEcCtD
Furosemide—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000454	0.00258	CcSEcCtD
Furosemide—Irritability—Methotrexate—ankylosing spondylitis	0.000444	0.00252	CcSEcCtD
Furosemide—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000441	0.0025	CcSEcCtD
Furosemide—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000439	0.00249	CcSEcCtD
Furosemide—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.000435	0.00247	CcSEcCtD
Furosemide—Vision blurred—Prednisolone—ankylosing spondylitis	0.000434	0.00246	CcSEcCtD
Furosemide—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.000434	0.00246	CcSEcCtD
Furosemide—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000434	0.00246	CcSEcCtD
Furosemide—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000426	0.00241	CcSEcCtD
Furosemide—Visual impairment—Betamethasone—ankylosing spondylitis	0.000426	0.00241	CcSEcCtD
Furosemide—Erythema—Triamcinolone—ankylosing spondylitis	0.000424	0.0024	CcSEcCtD
Furosemide—Erythema—Methylprednisolone—ankylosing spondylitis	0.000423	0.0024	CcSEcCtD
Furosemide—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000423	0.0024	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000419	0.00237	CcSEcCtD
Furosemide—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000415	0.00235	CcSEcCtD
Furosemide—Vertigo—Prednisolone—ankylosing spondylitis	0.000414	0.00235	CcSEcCtD
Furosemide—Eye disorder—Betamethasone—ankylosing spondylitis	0.000413	0.00234	CcSEcCtD
Furosemide—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000413	0.00234	CcSEcCtD
Furosemide—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000401	0.00227	CcSEcCtD
Furosemide—Angiopathy—Betamethasone—ankylosing spondylitis	0.000401	0.00227	CcSEcCtD
Furosemide—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000398	0.00226	CcSEcCtD
Furosemide—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000395	0.00224	CcSEcCtD
Furosemide—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000395	0.00224	CcSEcCtD
Furosemide—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000394	0.00223	CcSEcCtD
Furosemide—Erythema—Dexamethasone—ankylosing spondylitis	0.000385	0.00218	CcSEcCtD
Furosemide—Erythema—Betamethasone—ankylosing spondylitis	0.000385	0.00218	CcSEcCtD
Furosemide—Vertigo—Triamcinolone—ankylosing spondylitis	0.000381	0.00216	CcSEcCtD
Furosemide—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00038	0.00216	CcSEcCtD
Furosemide—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000376	0.00213	CcSEcCtD
Furosemide—Shock—Prednisolone—ankylosing spondylitis	0.00037	0.0021	CcSEcCtD
Furosemide—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000367	0.00208	CcSEcCtD
Furosemide—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000364	0.00206	CcSEcCtD
Furosemide—Eye disorder—Prednisone—ankylosing spondylitis	0.00036	0.00204	CcSEcCtD
Furosemide—Drowsiness—Methotrexate—ankylosing spondylitis	0.000358	0.00203	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000358	0.00203	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000355	0.00201	CcSEcCtD
Furosemide—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000353	0.002	CcSEcCtD
Furosemide—Renal failure—Methotrexate—ankylosing spondylitis	0.000352	0.002	CcSEcCtD
Furosemide—Angiopathy—Prednisone—ankylosing spondylitis	0.000349	0.00198	CcSEcCtD
Furosemide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000348	0.00197	CcSEcCtD
Furosemide—Immune system disorder—Prednisone—ankylosing spondylitis	0.000348	0.00197	CcSEcCtD
Furosemide—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000346	0.00196	CcSEcCtD
Furosemide—Vertigo—Dexamethasone—ankylosing spondylitis	0.000346	0.00196	CcSEcCtD
Furosemide—Vertigo—Betamethasone—ankylosing spondylitis	0.000346	0.00196	CcSEcCtD
Furosemide—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000345	0.00196	CcSEcCtD
Furosemide—Arrhythmia—Prednisone—ankylosing spondylitis	0.000344	0.00195	CcSEcCtD
Furosemide—Sweating—Methotrexate—ankylosing spondylitis	0.000343	0.00195	CcSEcCtD
Furosemide—Shock—Triamcinolone—ankylosing spondylitis	0.00034	0.00193	CcSEcCtD
Furosemide—Shock—Methylprednisolone—ankylosing spondylitis	0.00034	0.00193	CcSEcCtD
Furosemide—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000339	0.00192	CcSEcCtD
Furosemide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000339	0.00192	CcSEcCtD
Furosemide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000338	0.00192	CcSEcCtD
Furosemide—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000335	0.0019	CcSEcCtD
Furosemide—Erythema—Prednisone—ankylosing spondylitis	0.000335	0.0019	CcSEcCtD
Furosemide—Malnutrition—Prednisone—ankylosing spondylitis	0.000335	0.0019	CcSEcCtD
Furosemide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000334	0.0019	CcSEcCtD
Furosemide—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000334	0.0019	CcSEcCtD
Furosemide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000334	0.00189	CcSEcCtD
Furosemide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000323	0.00183	CcSEcCtD
Furosemide—Pain—Prednisolone—ankylosing spondylitis	0.000322	0.00182	CcSEcCtD
Furosemide—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000318	0.0018	CcSEcCtD
Furosemide—Vision blurred—Prednisone—ankylosing spondylitis	0.000316	0.00179	CcSEcCtD
Furosemide—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000315	0.00179	CcSEcCtD
Furosemide—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000314	0.00178	CcSEcCtD
Furosemide—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000314	0.00178	CcSEcCtD
Furosemide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000311	0.00176	CcSEcCtD
Furosemide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00031	0.00176	CcSEcCtD
Furosemide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00031	0.00176	CcSEcCtD
Furosemide—Visual impairment—Methotrexate—ankylosing spondylitis	0.00031	0.00176	CcSEcCtD
Furosemide—Anaemia—Prednisone—ankylosing spondylitis	0.00031	0.00176	CcSEcCtD
Furosemide—Shock—Betamethasone—ankylosing spondylitis	0.000309	0.00175	CcSEcCtD
Furosemide—Shock—Dexamethasone—ankylosing spondylitis	0.000309	0.00175	CcSEcCtD
Furosemide—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000308	0.00175	CcSEcCtD
Furosemide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000308	0.00175	CcSEcCtD
Furosemide—Agitation—Prednisone—ankylosing spondylitis	0.000308	0.00175	CcSEcCtD
Furosemide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000307	0.00174	CcSEcCtD
Furosemide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000307	0.00174	CcSEcCtD
Furosemide—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000304	0.00172	CcSEcCtD
Furosemide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000303	0.00172	CcSEcCtD
Furosemide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000303	0.00172	CcSEcCtD
Furosemide—Vertigo—Prednisone—ankylosing spondylitis	0.000301	0.00171	CcSEcCtD
Furosemide—Eye disorder—Methotrexate—ankylosing spondylitis	0.000301	0.0017	CcSEcCtD
Furosemide—Tinnitus—Methotrexate—ankylosing spondylitis	0.0003	0.0017	CcSEcCtD
Furosemide—Anorexia—Dexamethasone—ankylosing spondylitis	0.000299	0.0017	CcSEcCtD
Furosemide—Anorexia—Betamethasone—ankylosing spondylitis	0.000299	0.0017	CcSEcCtD
Furosemide—Urticaria—Prednisolone—ankylosing spondylitis	0.000299	0.00169	CcSEcCtD
Furosemide—Fatigue—Triamcinolone—ankylosing spondylitis	0.000298	0.00169	CcSEcCtD
Furosemide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000298	0.00169	CcSEcCtD
Furosemide—Pain—Triamcinolone—ankylosing spondylitis	0.000296	0.00168	CcSEcCtD
Furosemide—Hypotension—Dexamethasone—ankylosing spondylitis	0.000293	0.00166	CcSEcCtD
Furosemide—Hypotension—Betamethasone—ankylosing spondylitis	0.000293	0.00166	CcSEcCtD
Furosemide—Angiopathy—Methotrexate—ankylosing spondylitis	0.000292	0.00165	CcSEcCtD
Furosemide—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00029	0.00165	CcSEcCtD
Furosemide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000285	0.00162	CcSEcCtD
Furosemide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000284	0.00161	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000283	0.00161	CcSEcCtD
Furosemide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000282	0.0016	CcSEcCtD
Furosemide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000282	0.0016	CcSEcCtD
Furosemide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000282	0.0016	CcSEcCtD
Furosemide—Erythema—Methotrexate—ankylosing spondylitis	0.00028	0.00159	CcSEcCtD
Furosemide—Malnutrition—Methotrexate—ankylosing spondylitis	0.00028	0.00159	CcSEcCtD
Furosemide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000277	0.00157	CcSEcCtD
Furosemide—Urticaria—Triamcinolone—ankylosing spondylitis	0.000275	0.00156	CcSEcCtD
Furosemide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000274	0.00156	CcSEcCtD
Furosemide—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000274	0.00155	CcSEcCtD
Furosemide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000274	0.00155	CcSEcCtD
Furosemide—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000273	0.00155	CcSEcCtD
Furosemide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000273	0.00155	CcSEcCtD
Furosemide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000273	0.00155	CcSEcCtD
Furosemide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000273	0.00155	CcSEcCtD
Furosemide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000271	0.00154	CcSEcCtD
Furosemide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000271	0.00154	CcSEcCtD
Furosemide—Fatigue—Betamethasone—ankylosing spondylitis	0.000271	0.00153	CcSEcCtD
Furosemide—Fatigue—Dexamethasone—ankylosing spondylitis	0.000271	0.00153	CcSEcCtD
Furosemide—Shock—Prednisone—ankylosing spondylitis	0.000269	0.00153	CcSEcCtD
Furosemide—Pain—Dexamethasone—ankylosing spondylitis	0.000268	0.00152	CcSEcCtD
Furosemide—Pain—Betamethasone—ankylosing spondylitis	0.000268	0.00152	CcSEcCtD
Furosemide—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000268	0.00152	CcSEcCtD
Furosemide—Skin disorder—Prednisone—ankylosing spondylitis	0.000266	0.00151	CcSEcCtD
Furosemide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000264	0.0015	CcSEcCtD
Furosemide—Vision blurred—Methotrexate—ankylosing spondylitis	0.000264	0.0015	CcSEcCtD
Furosemide—Anorexia—Prednisone—ankylosing spondylitis	0.000261	0.00148	CcSEcCtD
Furosemide—Anaemia—Methotrexate—ankylosing spondylitis	0.000259	0.00147	CcSEcCtD
Furosemide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000259	0.00147	CcSEcCtD
Furosemide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000259	0.00147	CcSEcCtD
Furosemide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000257	0.00146	CcSEcCtD
Furosemide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000257	0.00146	CcSEcCtD
Furosemide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000255	0.00145	CcSEcCtD
Furosemide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000254	0.00144	CcSEcCtD
Furosemide—Vertigo—Methotrexate—ankylosing spondylitis	0.000252	0.00143	CcSEcCtD
Furosemide—Leukopenia—Methotrexate—ankylosing spondylitis	0.000251	0.00142	CcSEcCtD
Furosemide—Urticaria—Dexamethasone—ankylosing spondylitis	0.000249	0.00141	CcSEcCtD
Furosemide—Urticaria—Betamethasone—ankylosing spondylitis	0.000249	0.00141	CcSEcCtD
Furosemide—Dizziness—Prednisolone—ankylosing spondylitis	0.000249	0.00141	CcSEcCtD
Furosemide—Asthenia—Triamcinolone—ankylosing spondylitis	0.000248	0.00141	CcSEcCtD
Furosemide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000248	0.00141	CcSEcCtD
Furosemide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000248	0.00141	CcSEcCtD
Furosemide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000248	0.00141	CcSEcCtD
Furosemide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000248	0.00141	CcSEcCtD
Furosemide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000248	0.0014	CcSEcCtD
Furosemide—Paraesthesia—Prednisone—ankylosing spondylitis	0.000245	0.00139	CcSEcCtD
Furosemide—Pruritus—Triamcinolone—ankylosing spondylitis	0.000245	0.00139	CcSEcCtD
Furosemide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000244	0.00139	CcSEcCtD
Furosemide—Decreased appetite—Prednisone—ankylosing spondylitis	0.000238	0.00135	CcSEcCtD
Furosemide—Rash—Prednisolone—ankylosing spondylitis	0.000237	0.00135	CcSEcCtD
Furosemide—Dermatitis—Prednisolone—ankylosing spondylitis	0.000237	0.00134	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000237	0.00134	CcSEcCtD
Furosemide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000236	0.00134	CcSEcCtD
Furosemide—Fatigue—Prednisone—ankylosing spondylitis	0.000236	0.00134	CcSEcCtD
Furosemide—Headache—Prednisolone—ankylosing spondylitis	0.000236	0.00134	CcSEcCtD
Furosemide—Constipation—Prednisone—ankylosing spondylitis	0.000234	0.00133	CcSEcCtD
Furosemide—Confusional state—Methotrexate—ankylosing spondylitis	0.00023	0.00131	CcSEcCtD
Furosemide—Dizziness—Triamcinolone—ankylosing spondylitis	0.000229	0.0013	CcSEcCtD
Furosemide—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000228	0.0013	CcSEcCtD
Furosemide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000228	0.00129	CcSEcCtD
Furosemide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000225	0.00128	CcSEcCtD
Furosemide—Asthenia—Betamethasone—ankylosing spondylitis	0.000225	0.00128	CcSEcCtD
Furosemide—Asthenia—Dexamethasone—ankylosing spondylitis	0.000225	0.00128	CcSEcCtD
Furosemide—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000224	0.00127	CcSEcCtD
Furosemide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000224	0.00127	CcSEcCtD
Furosemide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000224	0.00127	CcSEcCtD
Furosemide—Nausea—Prednisolone—ankylosing spondylitis	0.000223	0.00127	CcSEcCtD
Furosemide—Pruritus—Dexamethasone—ankylosing spondylitis	0.000222	0.00126	CcSEcCtD
Furosemide—Pruritus—Betamethasone—ankylosing spondylitis	0.000222	0.00126	CcSEcCtD
Furosemide—Skin disorder—Methotrexate—ankylosing spondylitis	0.000222	0.00126	CcSEcCtD
Furosemide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000221	0.00125	CcSEcCtD
Furosemide—Vomiting—Triamcinolone—ankylosing spondylitis	0.00022	0.00125	CcSEcCtD
Furosemide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000219	0.00124	CcSEcCtD
Furosemide—Rash—Triamcinolone—ankylosing spondylitis	0.000218	0.00124	CcSEcCtD
Furosemide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000218	0.00124	CcSEcCtD
Furosemide—Anorexia—Methotrexate—ankylosing spondylitis	0.000218	0.00124	CcSEcCtD
Furosemide—Rash—Methylprednisolone—ankylosing spondylitis	0.000218	0.00123	CcSEcCtD
Furosemide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000217	0.00123	CcSEcCtD
Furosemide—Urticaria—Prednisone—ankylosing spondylitis	0.000217	0.00123	CcSEcCtD
Furosemide—Headache—Triamcinolone—ankylosing spondylitis	0.000217	0.00123	CcSEcCtD
Furosemide—Headache—Methylprednisolone—ankylosing spondylitis	0.000216	0.00123	CcSEcCtD
Furosemide—Abdominal pain—Prednisone—ankylosing spondylitis	0.000216	0.00123	CcSEcCtD
Furosemide—Body temperature increased—Prednisone—ankylosing spondylitis	0.000216	0.00123	CcSEcCtD
Furosemide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000215	0.00122	CcSEcCtD
Furosemide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000215	0.00122	CcSEcCtD
Furosemide—Hypotension—Methotrexate—ankylosing spondylitis	0.000214	0.00121	CcSEcCtD
Furosemide—Dizziness—Dexamethasone—ankylosing spondylitis	0.000208	0.00118	CcSEcCtD
Furosemide—Dizziness—Betamethasone—ankylosing spondylitis	0.000208	0.00118	CcSEcCtD
Furosemide—Nausea—Triamcinolone—ankylosing spondylitis	0.000206	0.00117	CcSEcCtD
Furosemide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000205	0.00116	CcSEcCtD
Furosemide—Nausea—Methylprednisolone—ankylosing spondylitis	0.000205	0.00116	CcSEcCtD
Furosemide—Somnolence—Methotrexate—ankylosing spondylitis	0.000203	0.00115	CcSEcCtD
Furosemide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000201	0.00114	CcSEcCtD
Furosemide—Vomiting—Betamethasone—ankylosing spondylitis	0.0002	0.00113	CcSEcCtD
Furosemide—Vomiting—Dexamethasone—ankylosing spondylitis	0.0002	0.00113	CcSEcCtD
Furosemide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000199	0.00113	CcSEcCtD
Furosemide—Rash—Dexamethasone—ankylosing spondylitis	0.000198	0.00112	CcSEcCtD
Furosemide—Rash—Betamethasone—ankylosing spondylitis	0.000198	0.00112	CcSEcCtD
Furosemide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000198	0.00112	CcSEcCtD
Furosemide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000198	0.00112	CcSEcCtD
Furosemide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000197	0.00112	CcSEcCtD
Furosemide—Fatigue—Methotrexate—ankylosing spondylitis	0.000197	0.00112	CcSEcCtD
Furosemide—Headache—Dexamethasone—ankylosing spondylitis	0.000197	0.00112	CcSEcCtD
Furosemide—Headache—Betamethasone—ankylosing spondylitis	0.000197	0.00112	CcSEcCtD
Furosemide—Asthenia—Prednisone—ankylosing spondylitis	0.000196	0.00111	CcSEcCtD
Furosemide—Pain—Methotrexate—ankylosing spondylitis	0.000195	0.00111	CcSEcCtD
Furosemide—Pruritus—Prednisone—ankylosing spondylitis	0.000193	0.0011	CcSEcCtD
Furosemide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000188	0.00107	CcSEcCtD
Furosemide—Diarrhoea—Prednisone—ankylosing spondylitis	0.000187	0.00106	CcSEcCtD
Furosemide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000187	0.00106	CcSEcCtD
Furosemide—Nausea—Betamethasone—ankylosing spondylitis	0.000186	0.00106	CcSEcCtD
Furosemide—Nausea—Dexamethasone—ankylosing spondylitis	0.000186	0.00106	CcSEcCtD
Furosemide—Urticaria—Methotrexate—ankylosing spondylitis	0.000182	0.00103	CcSEcCtD
Furosemide—Dizziness—Prednisone—ankylosing spondylitis	0.000181	0.00103	CcSEcCtD
Furosemide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000181	0.00102	CcSEcCtD
Furosemide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000181	0.00102	CcSEcCtD
Furosemide—Vomiting—Prednisone—ankylosing spondylitis	0.000174	0.000986	CcSEcCtD
Furosemide—Rash—Prednisone—ankylosing spondylitis	0.000172	0.000978	CcSEcCtD
Furosemide—Dermatitis—Prednisone—ankylosing spondylitis	0.000172	0.000977	CcSEcCtD
Furosemide—Headache—Prednisone—ankylosing spondylitis	0.000171	0.000971	CcSEcCtD
Furosemide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000168	0.000955	CcSEcCtD
Furosemide—Asthenia—Methotrexate—ankylosing spondylitis	0.000164	0.00093	CcSEcCtD
Furosemide—Nausea—Prednisone—ankylosing spondylitis	0.000162	0.000921	CcSEcCtD
Furosemide—Pruritus—Methotrexate—ankylosing spondylitis	0.000162	0.000917	CcSEcCtD
Furosemide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000156	0.000887	CcSEcCtD
Furosemide—Dizziness—Methotrexate—ankylosing spondylitis	0.000151	0.000857	CcSEcCtD
Furosemide—Vomiting—Methotrexate—ankylosing spondylitis	0.000145	0.000824	CcSEcCtD
Furosemide—Rash—Methotrexate—ankylosing spondylitis	0.000144	0.000817	CcSEcCtD
Furosemide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000144	0.000816	CcSEcCtD
Furosemide—Headache—Methotrexate—ankylosing spondylitis	0.000143	0.000812	CcSEcCtD
Furosemide—Nausea—Methotrexate—ankylosing spondylitis	0.000136	0.00077	CcSEcCtD
